1. Home
  2. RGR vs ARCT Comparison

RGR vs ARCT Comparison

Compare RGR & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGR
  • ARCT
  • Stock Information
  • Founded
  • RGR 1949
  • ARCT 2013
  • Country
  • RGR United States
  • ARCT United States
  • Employees
  • RGR N/A
  • ARCT N/A
  • Industry
  • RGR Ordnance And Accessories
  • ARCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • RGR Industrials
  • ARCT Health Care
  • Exchange
  • RGR Nasdaq
  • ARCT Nasdaq
  • Market Cap
  • RGR 616.8M
  • ARCT 298.3M
  • IPO Year
  • RGR N/A
  • ARCT N/A
  • Fundamental
  • Price
  • RGR $35.62
  • ARCT $13.27
  • Analyst Decision
  • RGR
  • ARCT Strong Buy
  • Analyst Count
  • RGR 0
  • ARCT 8
  • Target Price
  • RGR N/A
  • ARCT $52.83
  • AVG Volume (30 Days)
  • RGR 195.1K
  • ARCT 474.4K
  • Earning Date
  • RGR 07-30-2025
  • ARCT 08-04-2025
  • Dividend Yield
  • RGR 1.97%
  • ARCT N/A
  • EPS Growth
  • RGR N/A
  • ARCT N/A
  • EPS
  • RGR 1.83
  • ARCT N/A
  • Revenue
  • RGR $534,561,000.00
  • ARCT $143,680,000.00
  • Revenue This Year
  • RGR N/A
  • ARCT N/A
  • Revenue Next Year
  • RGR $1.89
  • ARCT $34.79
  • P/E Ratio
  • RGR $19.39
  • ARCT N/A
  • Revenue Growth
  • RGR 0.65
  • ARCT 15.38
  • 52 Week Low
  • RGR $32.74
  • ARCT $8.04
  • 52 Week High
  • RGR $46.40
  • ARCT $25.88
  • Technical
  • Relative Strength Index (RSI)
  • RGR 44.14
  • ARCT 51.35
  • Support Level
  • RGR $35.36
  • ARCT $13.25
  • Resistance Level
  • RGR $36.36
  • ARCT $15.20
  • Average True Range (ATR)
  • RGR 0.58
  • ARCT 0.97
  • MACD
  • RGR -0.04
  • ARCT -0.04
  • Stochastic Oscillator
  • RGR 30.14
  • ARCT 30.20

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

Share on Social Networks: